Evaluation of doxorubicin in three-dimensional culture of breast cancer cells and the response in PI3K/AKT/PTEN signaling pathways: a pilot study. (3rd July 2022)
- Record Type:
- Journal Article
- Title:
- Evaluation of doxorubicin in three-dimensional culture of breast cancer cells and the response in PI3K/AKT/PTEN signaling pathways: a pilot study. (3rd July 2022)
- Main Title:
- Evaluation of doxorubicin in three-dimensional culture of breast cancer cells and the response in PI3K/AKT/PTEN signaling pathways: a pilot study
- Authors:
- Gobbo, Marina Guimarães
de Mendonça Fernandes, Gláucia Maria
Fernandes-Ferreira, Rafael
Caires, Lennon Pereira
Caldas, Heloisa Cristina
de Campos Zuccari, Débora Aparecida Pires
Bordin-Junior, Newton Antonio
Gonçalves Vidotti, Giovana Aparecida
Souza, Doroteia Rossi Silva - Abstract:
- ABSTRACT: Breast cancer (BC) has a high mortality rate, which is attributed to the absence of effective treatment markers. Doxorubicin (DOX) was evaluated by molecular docking in vitro in cultured BC spheroids and its association with genes involved in the PI3K/AKT/PTEN signaling pathway. Spheroids were obtained from a primary BC. The selected compound was used for molecular docking experiments. Spheroids were treated with DOX for 1 (D1) and 9 (D9) days. qPCR was used to evaluate PIK3CA, HIF-1α, VEGF-A, PTEN expression. Treatment with DOX (1 µM) significantly increased the number of spheroids (D1), whereas exposure to chemotherapy at 2 µM on D9 was more effective. DOX treatment resulted in significantly higher expression of VEGF-A, HIF-1α and PIK3CA by D1 and HIF-1α and PTEN were upregulated by D9. Compared to treatment on D1 with D9 (1 μM) had significantly higher PTEN and lower PIK3CA gene expression. The genes HIF-1α and PTEN were more expressed with 2 μM of DOX while VEGF-A was downregulated. D1 vs. D9 exhibited reduced VEGF-A, HIF-1α, and PIK3CA expression and upregulation of PTEN expression. DOX effects at the molecular mechanisms can be involved the modulation of genes related to angiogenesis cell proliferation and tumor growth in BC tissue spheroids.
- Is Part Of:
- Women & health. Volume 62:Number 6(2022)
- Journal:
- Women & health
- Issue:
- Volume 62:Number 6(2022)
- Issue Display:
- Volume 62, Issue 6 (2022)
- Year:
- 2022
- Volume:
- 62
- Issue:
- 6
- Issue Sort Value:
- 2022-0062-0006-0000
- Page Start:
- 467
- Page End:
- 475
- Publication Date:
- 2022-07-03
- Subjects:
- Breast cancer -- chemotherapy -- three-dimensional culture
Women -- Health and hygiene -- Periodicals
Women -- Health and hygiene -- United States -- Periodicals
Women's health services -- Periodicals
Gynecology -- Periodicals
Women in medicine -- Periodicals
613.0424405 - Journal URLs:
- http://www.informaworld.com/smpp/title~db=all~content=t792306982~tab=issueslist ↗
http://www.tandfonline.com/loi/wwah20 ↗
http://www.tandfonline.com/ ↗
http://firstsearch.oclc.org ↗ - DOI:
- 10.1080/03630242.2022.2085842 ↗
- Languages:
- English
- ISSNs:
- 0363-0242
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9343.260000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 22578.xml